Behavioral and electroencephalographic manifestations of thioacetamide-induced encephalopathy: Possible mechanisms of neurotoxic effects

Archives of Biological Sciences

Volumn 64, Issue 3, 2012, Pages 829-842

  Mladenovic D ^a   Hrncic D ^a   Rasic Markovic A ^a   Stanojlović, Oliver A ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Behavioral manifestations; Electroencephalography; Hepatic encephalopathy; Hyperammonemia; Thioacetamide

Indexed keywords

EID: 84867849130     PISSN: 03544664     EISSN: None     Source Type: Journal    
DOI: 10.2298/ABS1203829M     Document Type: Article

References (88)

1. Aguilar, M.A., Miñarro, J., and V. Felipo (2000). Chronic moderate hyperammonemia impairs active and passive avoidance behaviour and conditional discrimination learning in rats. Exp. Neurol. 161, 704-713.
2. Ahboucha, S., and R.F. Butterworth (2008). The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem. Inter. 52, 575-587.
3. Ahboucha, S., Pomier-Layrargues, G., Mamer, O., and R.F. Butterworth (2006). Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem. Int. 49, 372-378.
4. Albrecht, J., Hilgier, W., and U. Rafalowska (1990). Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: An adaptive response? J. Neurosci. Res. 25, 125-130.
5. Albrecht, J., and E.A. Jones (1999). Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci. 170, 138-146.
6. Albrecht, J., Zielińska, M., and M.D. Norenberg (2010). Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal. Biochem. Pharmacol. 80, 1303-1308.
7. Amodio, P., Del Piccolo, F., Marchetti, P., Angeli, P., Iemmolo, R., Caregaro, L., Merkel, C., Gerunda, G., and A. Gatta (1999a). Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29, 1662-1667.
8. Amodio, P., and A. Gatta (2005). Neurophysiological investigation of hepatic encephalopathy. Metab. Brain Dis. 20, 369-739.
9. Amodio, P., Marchetti, P., Del Piccolo, F., de Tourtchaninoff, M., Varghese, P., Zuliani, C., Campo, G., Gatta, A., and J.M. Guérit (1999b). Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin. Neurophysiol. 110, 1334-1344.
10. Amodio, P., Pellegrini, A., Ubiali, E., Mathy, I., Piccolo, F.D., Orsato, R., Gatta, A., and J.M. Guerit (2006). The EEG assessment of low-grade hepatic encephalopathy: Comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin. Neurophysiol. 117, 2243-2251.
11. Avraham, Y., Israeli, E., Gabbay, E., Okun, A., Zolotarev, O., Silberman, I., Ganzburg, V., Dagon, Y., Magen, I., Vorobia, L., Pappo, O., Mechoulam, R., Ilan, Y., and E.M. Berry (2006). Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiol. Dis. 21, 237-245.
12. Brusilow, S.W., and R. Traystman (1986). Letter to the editor. N. Engl. J. Med. 314, 786-797.
13. Cauli, O., López-Larrubia, P., Rodrigues, T.B., Cerdán, S., and V. Felipo (2007). Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors. J. Neurochem. 103, 1334-1343.
14. Cauli, O., Rodrigo, R., Llansola, M., Montoliu, C., Monfort, P., Piedrafita, B., El Mlili, N., Boix, J., Agusti, A., and V. Felipo (2009). Glutamatergic and GABAergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab. Brain Dis. 24, 69-80.
15. Chou, Y.C., Lin, S.B., Tsai, L.S., Tsai, H.I., and C.M. Lin (2003). Cholesterol deficiency increases the vulnerability of hippocampal glia in primary culture to glutamate-induced excitotoxicity. Neurochem. Int. 43, 197-209.
16. Córdoba, J. (2011). New assessment of hepatic encephalopathy. J. Hepatol. 54, 1030-1040.
17. 2+-dependent enzymes. J. Hepatol. 24, 460-467.
18. Dyroff, M.C., and R.A. Neal (1981). Identification of the major protein adduct formed in rat liver after thioacetamide administration. Cancer Res. 41, 3430-3435.
19. ElMlili, N., Boix, J., Ahabrach, H., Rodrigo, R., Errami, M., and V. Felipo (2010). Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum. J. Neurochem. 112, 1005-1014.
20. Faff-Michalak, L., and J. Albrecht (1991). Aspartate aminotransferase, malate dehydrogenase, and pyruvate carboxylase activities in rat cerebral synaptic and non-synaptic mitochondria: effects of in vitro treatment with ammonia, hyperammonemia and hepatic encephalopathy. Metab. Brain Dis. 6, 187-197.
21. Felipo, V. (2008). Hyperammonemia. Handbook of neurochemistry and molecular neurobiology. Vol. 24, 3rd ed. pp. 1-27, Kluwer Academic/Plenum, USA.
22. Felipo, V., and R. Butterworth (2002). Neurobiology of ammonia. Prog. Neurobiol. 67, 259-279.
23. Gammal, S.H., and E.A. Jones (1989). Hepatic encephalopathy. Med. Clin. North Am. 73, 793-813.
24. Ghosh, C., Dick, R.M., and S.F. Ali (1993). Iron/ascorbate-induced lipid peroxidation changes membrane fluidity and muscarinic cholinergic receptor binding in rat frontal cortex. Neurochem. Int. 23, 479-484.
25. Guerit, J.M., Amantini, A., Fischer, C., Kaplan, P.W., Mecarelli, O., Schnitzler, A., Ubiali, E., Amodio, P. and the members of the ISHEN commission on Neurophysiological Investigations. (2009). Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Inter. 29, 789-796.
26. Hagve, T.A., Christensen, E., Gronn, M., and B.O. Christophersen (1988). Regulation of the metabolism of polyunsaturated fatty acids. Scand. J. Clin. Lab. Invest. Suppl. 191, 33-46.
27. Hermenegildo, C., Marcaida, G., Montoliu, C., Grisolia, S., Miñana, M.D., and V. Felipo (1996). NMDA receptor antagonists prevent acute ammonia toxicity in mice. Neurochem. Res. 21, 1237-1244.
28. Hermenegildo, C., Monfort, P., and V. Felipo (2000). Activation of NMDA receptors in rat brain in vivo following acute ammonia intoxication. Characterization by in vivo brain microdialysis. Hepatology 31, 709-715.
29. Hertz, L., and Kala, G. (2007). Energy metabolism in brain cells: effects of elevated ammonia concentrations. Metab. Brain Dis. 22, 199-218.
30. Hertz, L., Yu, A.C., Kala, G., and A. Schousboe (2000). Neuronalastrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation. Neurochem. Int. 37, 83-102.
31. Hilgier, W., Benveniste, H., Diemer, N.H., and J. Albrecht (1991). Decreased glucose utilization in discrete brain regions of rat in thioacetamide-induced hepatic encephalopathy as measured with [3H]-deoxyglucose. Acta Neurol. Scand. 83, 353-355.
32. Hrnčić, D., Rašić-Marković, A., Šušić, V., Djuric, D., and O. Stanojlović (2009). Influence of NR2B-selective NMDA antagonist on lindane-induced seizures in rats. Pharmacology 84, 234-239.
33. Hunter, A.L., Holscher, M.A., and R.A. Neal (1977). Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system. J. Pharmacol. Exp. Ther. 200, 439-448.
34. Hunter, G.R., and G.B. Young (2010). Recovery of awareness after hyperacute hepatic encephalopathy with "flat" EEG, severe brain edema and deep coma. Neurocrit. Care 13, 247-251.
35. Itzhak, Y., Roig-Cantisano, A., Dombro, R.S., and M.D. Norenberg (1995). Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res. 705, 345-348.
36. Jalan, R., Shawcross, D., and N. Davies (2003). The molecular pathogenesis of hepatic encephalopathy. Inter. J. Biochem. Cell. Biol. 35, 1175-1181.
37. Jayakumar, A.R., Panickar, K.S., Murthy, Ch.R., and M.D. Norenberg (2006). Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J. Neurosci. 26, 4774-4784.
38. Kamataki, T., Maeda, K., Shimada, M., and R. Kato (1986). Effects of phenobarbital, 3-methylcholanthrene and polychlorinated biphenyls on sex-specific forms of cytochrome P450 in liver microsomes of rats. J. Biochem. Tokyo 99, 841-845.
39. Kosenko, E., Kaminsky, Y., Grau, E., Miñana, M.D., Marcaida, G., Grisolia, S., and V. Felipo (1994). Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and of Na/K ATP-ase. J. Neurochem. 63, 2172-2178.
40. Kosenko, E., Kaminsky, Y., Lopata, O., Muravyov, N., and V. Felipo (1999). Blocking NMDA receptors prevents the oxidative stress induced by acute ammonia intoxication. Free Rad. Biol. Med. 26, 1369-1374.
41. Kosenko, E., Kaminsky, Y., Stavroskaya, I.G., and V. Felipo (2000). Alteration of mitochondrial calcium homeostasis by ammonia-induced activation of NMDA receptors in rat brain in vivo. Brain Res. 880, 139-146.
42. Kullmann, F., Hollerbach, S., Lock, G., Holstege, A., Dierks, T., and J. Schölmerich (2001). Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease. Eur. J. Gastroenterol. Hepatol. 13, 513-522.
43. Méndez, M., Méndez-López, M., Lopez, L., Aller, M.A., Arias, J., and J.L. Arias (2008a). Mammillary body alterations and spatial memory impairment in Wistar rats with thioacetamide-induced cirrhosis. Brain Res. 1233, 185-195.
44. Méndez, M., Méndez-López, M., Lopez, L., Aller, M.A., Arias, J., Cimadevilla, J.M., and J.L. Arias (2008b). Spatial memory alterations in three models of hepatic encephalopathy. Behav. Brain Res. 188, 32-40.
45. Miranda, A.S., Rodrigues, D.H., Vieira, L.B., Lima, C.X., Rachid, M.A., Vidigal, P.V., Gomez, M.V., Reis, H.J., Guatimosim, C., and A.L. Teixeira (2010). A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice. a behavioral and neurochemical study. Arq. Neuropsiquiatr. 68, 597-602.
46. Mladenović, D., Krstic, D., Colovic, M., Radosavljević, T., Rašić-Marković, A., Hrnčić, D., Macut, Dj., and O. Stanojlović (2012a). Different sensitivity of various brain structures to thioacetamide-induced lipid peroxidation. Med. Chem. 8, 52-58.
47. Mladenović, D., Hrnčić, D., Vučević, D., Radosavljević, T., Loncar-Stevanović, H., Petrović, J., Susic, V., Djuric, D., and O. Stanojlović (2007). Ethanol suppressed seizures in lindane- treated rats. Electroencephalographic and behavioral studies. J. Physiol. Pharmacol. 58, 641-654.
48. Mladenović, D., Radosavljević, T., Hrnčić, D., Rašić-Marković, A., Puškaš, N., Maksić, N., Djuric, D., and O. Stanojlović (2012b). Behavioral and electroencephalographic manifestations of thioacetamide-induced hepatic encephalopathy in rats. Can. J. Physiol. Pharmacol. (in press).
49. Monfort, P., Corbalán, R., Martinez, L., López-Talavera, J.C., Córdoba, J., and V. Felipo (2001). Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis. Neuroscience 104, 1119-1125.
50. Monfort, P., Muñoz, M.D., and V. Felipo (2004). Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation cAMP-degrading phosphodiesterase by protein kinase G. Neurobiol. Dis. 15, 1-10.
51. Montagnese, S., Jackson, C., and M.Y. Morgan (2007). Spatiotemporal decomposition of the electroencephalogram in patients with cirrhosis. J. Hepatol. 46, 447-458.
52. Mori, W., and H. Aoyama (1983). Statistical study on fulminant liver disease in Japan. Appl. Pathol. 1, 209-222.
53. Moriyama, M., Jayakumar, A.R., Tong, X.Y., and M.D. Norenberg (2010). Role of mitogen-activated protein kinases in the mechanism of oxidant-induced cell swelling in cultured astrocytes. J. Neurosci. Res. 88, 2450-2458.
54. Moroni, F., Lombardi, G., Moneti, G., and C. Cortesini (1983). The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J. Neurochem. 40, 850-854.
55. Muñoz, D., Monfort, P., and V. Felipo (2000). Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem. Res. 25, 437-441.
56. Norenberg, M.D. (1977). A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab. Invest. 36, 618-627.
57. Norenberg, M.D., Huo, Z., Neary, J.T., and A. Roig-Cantesano (1997a). The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission. Glia 21, 124-133.
58. Norenberg, M.D., Itzhak, Y., and A.S. Bender (1997b). The peripheral benzodiazepine receptor and neurosteroids in HE. Adv. Exp. Med. Biol. 420, 95-111.
59. Norton, N.S., McConnell, J.R., and J.F. Rodriguez-Sierra (1997). Behavioral and physiological sex differences observed in an animal model of fulminant hepatic encephalopathy in the rat. Physiol. Behav. 62, 1113-1124.
60. Nozu, F., Takeyama, N., and T. Tanaka (1992). Changes of hepatic fatty acid metabolism produced by chronic thioacetamide administration in rats. Hepatology 15, 1099-1106.
61. Olesen, S.S., Graversen, C., Hansen, T.M., Blauenfeldt, R.A., Hansen, J.B., Steimle, K., and A.M. Drewes (2011). Spectral and dynamic electroencephalogram abnormalities are correlated to psychometric test performance in hepatic encephalopathy. Scand. J. Gastroenterol. 46, 988-996.
62. Pasantes-Morales, H., Franco, R., Ordaz, B., and L.D. Ochoa (2002). Mechanisms counteracting swelling in brain cells during hyponatremia. Arch. Med. Res. 33, 237-244.
63. Peeling, J., Shoemaker, L., Gauthier, T., Benarroch, A., Sutherland, G.R., and G.Y. Minuk (1993). Cerebral metabolic and histological effects of thioacetamide-induced liver failure. Am. J. Physiol. 265, G572-G578.
64. Porter, W.R., Gudzinowicz, M.J., and R.A. Neal (1979). Thioacetamide-induced hepatic necrosis: II. Pharmacokinetics of thioacetamide and thioacetamide-S-oxide in the rat. J. Pharmacol. Exp. Ther. 208, 386-391.
65. Rama-Rao, K.V., Reddy, P.V., Tong, X., and M.D. Norenberg (2010). Brain edema in acute liver failure: inhibition by Lhistidine. Am. J. Pathol. 176, 1400-1408.
66. Reddy, P.V.B., Murthy, Ch.R.K., and P. Reddanna (2004). Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats. Neurosci. Lett. 368, 15-20.
67. Rodrigo, R., Erceg, S., and V. Felipo (2005). Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex of patients with liver cirrhosis. Neurobiol. Dis. 19, 150-161.
68. Rodrigo, R., Erceg, S., Rodriguez-Diaz, J., Saez-Valero, J., Piedrafita, B., Suarez, I., and V. Felipo (2007). Glutamateinduced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure. J. Neurochem. 102, 51-64.
69. Rogers, D.C., Fisher, E.M., Brown, S.D., Peters, J., Hunter, A.J., and J.E. Martin (1997). Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 8, 711-713.
70. Sagales, T., Gimeno, V., de la Calzada, M.D., Casellas, F., Dolors-Macià, M., and M. Villar-Soriano (1990). Brain mapping analysis in patients with hepatic encephalopathy. Brain Topog. 2, 221-228.
71. Sanz, N., Díez-Fernández, C., Fernández-Simón, L., Alvarez, A., and M. Cascales, (1998). Necrogenic and regenerative responses of liver of newly weaned rats against a sublethal dose of thioacetamide. Biochim. Biophys. Acta 1384, 66-78.
72. Sathyasaikumar, K.V., Swapna, I., Reddy, P.V., Murthy, Ch.R., Dutta Gupta, A., Senthilkumaran, B., and P. Reddanna (2007). Fulminant hepatic failure in rats induces oxidative stress differentially in cerebral cortex, cerebellum and pons medulla. Neurochem. Res. 32, 517-524.
73. Sawant, S.P., Dnyanmote, A.V., Warbritton, A., Latendresse, J.R., and H.M. Mehendale (2006). Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity. Toxicol. Appl. Pharmacol. 211, 221-232.
74. Sinke, A.P., Jayakumar, A.R., Panickar, K.S., Moriyama, M., Reddy, P.V., and M.D. Norenberg (2008). NFkappaB in the mechanism of ammonia-induced astrocyte swelling in culture. J. Neurochem. 106, 2301-2311.
75. Swapna, I., Sathyasaikumar, K.V., Murthy, Ch.R.K., Dutta-Gupta, A., and B. Senthilkumaran (2006). Changes in cerebral membrane lipid composition and fluidity during thioacetamide-induced hepatic encephalopathy. J. Neurochem. 98, 1899-1907.
76. Tanigami, H., Rebel, A., Martin, L.J., Chen, T.Y., Brusilow, S.W., Traystman, R.J., and R.C. Koehler (2005). Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience 131, 437-449.
77. Terblanche, J., and R. Hickman (1991). Animal models of fulminant hepatic failure. Dig. Dis. Sci. 36, 770-774.
78. Túnez, I., Muñoz, M.C., Medina, F.J., Salcedo, M., Feijóo, M., and P. Montilla (2007). Comparison of melatonin, vitamina E and L-carnitine in the treatment of neuro- and hepatotoxicity induced by thioacetamide. Cell. Biochem. Funct. 25, 119-127.
79. Túnez, I., Muñoz, M.C., Villavicencio, M.A., Medina, F.J., de Prado, E.P., Espejo, I., Barcos, M., Salcedo, M., Feijóo, M., and P. Montilla (2005). Hepato- and neurotoxicity induced by thioacetamide: protective effects of melatonin and dimethyl sulfoxide. Pharmacol. Res. 52, 223-228.
80. Uehara, T., Hirode, M., Ono, A., Kiyosawa, N., Omura, K., Shimizu, T., Mizukawa, Y., Miyagishima, T., and T. Nagao (2008). A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology 250, 15-26.
81. Van der Rijt, C.C., Schalm, S.W., De Groot, G.H., and M. De Vlieger (1984). Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr. Clin. Neurophysiol. 57, 423-426.
82. Vogels, B.A., Maas, M.A., Daalhuisen, J., Quack, G., and R.A. Chamuleau (1997). Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 25, 820-827.
83. Wang, T., Shankar, K., Bucci, T.J., Warbritton, A., and H.M. Mehendale (2001). Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality. Toxicol. Appl. Pharmacol. 173, 27-37.
84. Wang, X., Zaidi, A., Pal, R., Garrett, A.S., Braceras, R., Chen, X.W., Michaelis, M.L., and E.K. Michaelis (2009). Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress. BMC Neurosci. 10, 12.
85. Wesierska, M., Klinowska, H.D., Adamska, I., Fresko, I., Sadowska, J., and J. Albrecht (2006). Cognitive flexibility but not cognitive coordination is affected in rats with toxic liver failure. Behav. Brain Res. 171, 70-77.
86. Willard-Mack, C.L., Koehler, R.C., Hirata, T., Cork, L.C., Takahashi, H., Traystman, R.J., and S.W. Brusilow (1996). Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 71, 589-599.
87. Wu, J.Y., Yue, J., and Y.Q. Feng (2011). Determination of brain cytochrome P450 2E1 activity in rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879, 260-266.
88. Yogalakshmi, B., Viswanathan, P., and C.V. Anuradha (2010). Investigation of antioxidant, anti-inflammatory and DNAprotective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 268, 204-212.